发明名称 Combination cancer therapy with bis(thiohydrazide) amide compounds
摘要 A method of treating a subject with cancer includes the step of co-administering to the subject over three to five weeks, a taxane in an amount of between about 243 mumol/m2 to 315 mumol/m2 (e.g., equivalent to paclitaxel in about 210-270 mg/m2); and a bis(thiohydrazide amide) in an amount between about 1473 mumol/m2 and about 1722 mumol/m2 (e.g., Compound (1) in about 590-690 mg/m2). The bis(thiohydrazide amide) is represented by Structural Formula (I), Y is a covalent bond or an optionally substituted straight chained hydrocarbyl group, or, Y, taken together with both >C=Z groups to which it is bonded, is an optionally substituted aromatic group. R1-R4 are independently -H, an optionally substituted aliphatic group, an optionally substituted aryl group, or R1 and R3 taken together with the carbon and nitrogen atoms to which they are bonded, and/or R2 and R4 taken together with the carbon and nitrogen atoms to which they are bonded, form a non-aromatic heterocyclic ring optionally fused to an aromatic ring. R7-R8 are independently -H, an optionally substituted aliphatic group, or an optionally substituted aryl group. Z is O or S.
申请公布号 US2009137682(A1) 申请公布日期 2009.05.28
申请号 US20060918357 申请日期 2006.04.13
申请人 DAHL THOMAS A 发明人 DAHL THOMAS A
分类号 A61K31/165;A61P35/00 主分类号 A61K31/165
代理机构 代理人
主权项
地址
您可能感兴趣的专利